Sarah MacRaild

1.4k total citations
10 papers, 227 citations indexed

About

Sarah MacRaild is a scholar working on Hematology, Molecular Biology and Immunology. According to data from OpenAlex, Sarah MacRaild has authored 10 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 4 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Sarah MacRaild's work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Sarah MacRaild is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Sarah MacRaild collaborates with scholars based in Australia, France and United Kingdom. Sarah MacRaild's co-authors include Jessica M. Salmon, Andrew W. Roberts, Adam Ivey, Chong Chyn Chua, Andrew H. Wei, Ian D. Davis, Stephen B. Ting, Shaun Fleming, John Reynolds and Fiona C. Brown and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Sarah MacRaild

10 papers receiving 226 citations

Peers

Countries citing papers authored by Sarah MacRaild

Since Specialization

Citations

This map shows the geographic impact of Sarah MacRaild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah MacRaild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah MacRaild more than expected).

Fields of papers citing papers by Sarah MacRaild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah MacRaild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah MacRaild. The network helps show where Sarah MacRaild may publish in the future.

Co-authorship network of co-authors of Sarah MacRaild

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah MacRaild. A scholar is included among the top collaborators of Sarah MacRaild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah MacRaild. Sarah MacRaild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy 2020 ·Journal of Clinical Oncology ·Chong Chyn Chua, Andrew W. Roberts, John Reynolds, Chun Yew Fong, Stephen B. Ting, Jessica M. Salmon, Sarah MacRaild, Adam Ivey, Ing Soo Tiong, Shaun Fleming, Fiona C. Brown, Sun Loo, Ian J. Majewski, Stefan K. Bohlander, Andrew H. Wei	117
2	Acquired Mutations in BAX Confer Resistance to BH3 Mimetics in Acute Myeloid Leukemia 2020 ·Blood ·Donia M. Moujalled, Fiona C. Brown, Giovanna Pomilio, Natasha S. Anstee, Véronique Litalien, Ella R. Thompson, (unknown), Sarah MacRaild, Chong Chyn Chua, Sébastien Banquet, Maïa Chanrion, (unknown), Marie Schoumacher, Marco J. Herold, Guillaume Lessène, Olivier Geneste, David C.S. Huang, Andrew W. Roberts, Piers Blombery, Andrew H. Wei	16
3	The Impact of Sorafenib on Phospho-FLT3 Inhibition and FLT3-ITD MRD after Chemotherapy: Correlative Studies from the Phase 2 Randomized Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16) 2020 ·Blood ·Natasha S. Anstee, Giovanna Pomilio, Mark J. Levis, Sarah MacRaild, Michael T. Murray, Tristan Rawling, Glen Kennedy, Andrew Grigg, Anthony P. Schwarer, Anoop Enjeti, James D’Rozario, Paula Marlton, Ian Bilmon, Adam Ivey, (unknown), Andrew W. Roberts, Andrew H. Wei	3
4	Anti-Leukemic Activity of Single Agent Venetoclax in Newly Diagnosed Acute Myeloid Leukemia: A Sub-Set Analysis of the Caveat Study 2019 ·Blood ·Chong Chyn Chua, John Reynolds, Jessica M. Salmon, Chun Yew Fong, Stephen B. Ting, Ing Soo Tiong, Shaun Fleming, Sarah MacRaild, Donia M. Moujalled, Giovanna Pomilio, Nik Cummings, Julie F. McManus, Adam Ivey, Purvi M. Kakadia, Stefan K. Bohlander, Andrew W. Roberts, Andrew H. Wei	6
5	Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity In AML 2018 ·Experimental Hematology ·Jessica M. Salmon, Giovanna Pomilio, Donia M. Moujalled, Sarah MacRaild, Charis E. Teh, Sewa Rijal, Adam Ivey, (unknown), Paul G. Ekert, Marie Schoumacher, Laurence Kraus‐Berthier, Ioana Kloos, Daniel H.D. Gray, Andrew H. Wei	2
6	Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity in AML 2018 ·Blood ·Jessica M. Salmon, Giovanna Pomilio, Donia M. Moujalled, Sarah MacRaild, Charis E. Teh, (unknown), Adam Ivey, (unknown), Paul G. Ekert, Laurence Kraus‐Berthier, Ioana Kloos, Marie Schoumacher, Daniel H.D. Gray, Andrew H. Wei	3
7	Molecular Patterns of Response and Outcome in the Chemotherapy and Venetoclax in Elderly AML Trial (CAVEAT study) 2018 ·Blood ·Andrew H. Wei, Chong Chyn Chua, Ing Soo Tiong, Chun Yew Fong, Stephen B. Ting, Sarah MacRaild, Jessica M. Salmon, Adam Ivey, John Nguyen, (unknown), Richard D. Hall, Shaun Fleming, Stefan K. Bohlander, John Reynolds, Andrew W. Roberts	15
8	A novel method for detecting antigen-specific human regulatory T cells 2012 ·Journal of Immunological Methods ·Lisa M. Ebert, Sarah MacRaild, Ian D. Davis, Jonathan Cebon, Weisan Chen	4
9	A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma 2012 ·PLoS ONE ·Lisa M. Ebert, Sarah MacRaild, Damien Zanker, Ian D. Davis, Jonathan Cebon, Weisan Chen	51
10	The Influence of the Zebrafish Genetic Background on Parkinson's Disease–Related Aspects 2011 ·Zebrafish ·Sandrine Bretaud, Sarah MacRaild, Philip W. Ingham, Oliver Bandmann	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact